Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2015, Article ID 676191, 4 pages
Case Report

Case Reports That Illustrate the Efficacy of SGLT2 Inhibitors in the Type 1 Diabetic Patient

Southside Endocrinology, 3928 Montclair Road, Suite 130, Mountain Brook, AL 35213, USA

Received 4 November 2014; Revised 3 February 2015; Accepted 6 February 2015

Academic Editor: Toshihiro Kita

Copyright © 2015 David S. H. Bell. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [6 citations]

The following is the list of published articles that have cited the current article.

  • Nimrah Bader, and Lubna Mirza, “Euglycemic Diabetic Ketoacidosis in a 27 year-old female patient with type-1-Diabetes treated with sodium-glucose cotransporter-2 (SGLT2) inhibitor Canagliflozin.,” Pakistan journal of medical sciences, vol. 32, no. 3, pp. 786–8, . View at Publisher · View at Google Scholar
  • Sanjay Kalra, Rakesh Sahay, and Yashdeep Gupta, “Sodium glucose transporter 2 (SGLT2) inhibition and ketogenesis.,” Indian journal of endocrinology and metabolism, vol. 19, no. 4, pp. 524–8, . View at Publisher · View at Google Scholar
  • Julia Hine, Heather Paterson, Esha Abrol, David Russell-Jones, and Roselle Herring, “SGLT inhibition and euglycaemic diabetic ketoacidosis,” Lancet Diabetes & Endocrinology, vol. 3, no. 7, pp. 503–504, 2015. View at Publisher · View at Google Scholar
  • Anne L. Peters, Elizabeth O. Buschur, John B. Buse, Pejman Cohan, Jamie C. Diner, and Irl B. Hirsch, “Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition,” Diabetes Care, vol. 38, no. 9, pp. 1687–1693, 2015. View at Publisher · View at Google Scholar
  • Yingying Yang, Shi Chen, Hui Pan, Yun Zou, Bo Wang, Guixia Wang, and Huijuan Zhu, “Safety and efficiency of SGLT2 inhibitor combining with insulin in subjects with diabetes: Systematic review and meta-analysis of randomized controlled trials.,” Medicine, vol. 96, no. 21, 2017. View at Publisher · View at Google Scholar
  • Gretchen Ray, Chelsea Rodriguez, Samantha Schulman, Preeyaporn Sarangarm, Michelle Bardack, and Matthew Bouchonville, “Empagliflozin-induced Diabetic Ketoacidosis Unmasking a Type 1 Diabetes Diagnosis,” Clinical Practice and Cases in Emergency Medicine, vol. 3, no. 2, pp. 140–143, 2019. View at Publisher · View at Google Scholar